Mirae Asset Global Investments Portfolio holdings
AUM
$28.7B
1-Year Return
20.96%
This Quarter Return
+7.12%
1 Year Return
+20.96%
3 Year Return
+114.88%
5 Year Return
+202.83%
10 Year Return
+496.23%
AUM
$20.1B
AUM Growth
-$26B
(-56%)
Cap. Flow
-$35.8B
Cap. Flow
% of AUM
-178.2%
Top 10 Holdings %
Top 10 Hldgs %
37.49%
Holding
2,693
New
259
Increased
178
Reduced
1,071
Closed
1,170
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$78.3M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$69.3M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$67.8M |
| 4 |
SPDR Portfolio Long Term Treasury ETF
SPTL
|
+$51.6M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$49.3M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$3.09B |
| 2 |
Microsoft
MSFT
|
+$2.03B |
| 3 |
Apple
AAPL
|
+$1.62B |
| 4 |
Amazon
AMZN
|
+$1.15B |
| 5 |
Meta Platforms (Facebook)
META
|
+$886M |
Sector Composition
| 1 | Technology | 34.49% |
| 2 | Consumer Discretionary | 8.59% |
| 3 | Communication Services | 8.54% |
| 4 | Healthcare | 6.84% |
| 5 | Financials | 4.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Coca-Cola Femsa
KOF
$18B
| $63K | ﹤0.01% |
+742
| New | +$63K |
|
1202
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.29B
| $63K | ﹤0.01% |
1,490
-21,800
| -94% | -$921K |
|
1203
Janux Therapeutics
JANX
$1.46B
| $62.4K | ﹤0.01% |
+1,548
| New | +$62.4K |
|
1204
Companhia Siderúrgica Nacional
SID
$2B
| $62.3K | ﹤0.01% |
26,852
-10,081
| -27% | -$23.4K |
|
1205
Urban Edge Properties
UE
$2.66B
| $61.8K | ﹤0.01% |
3,391
-48,979
| -94% | -$892K |
|
1206
Sphere Entertainment
SPHR
$2.06B
| $61.7K | ﹤0.01% |
1,750
-14,553
| -89% | -$513K |
|
1207
Casey's General Stores
CASY
$20.7B
| $61.3K | ﹤0.01% |
+160
| New | +$61.3K |
|
1208
Fortrea Holdings
FTRE
$929M
| $61.1K | ﹤0.01% |
+2,669
| New | +$61.1K |
|
1209
Columbia Sportswear
COLM
$2.99B
| $60.2K | ﹤0.01% |
767
-10,369
| -93% | -$813K |
|
1210
TransUnion
TRU
$18B
| $59.9K | ﹤0.01% |
+806
| New | +$59.9K |
|
|
EQC
1211
DELISTED
Equity Commonwealth
EQC
| $59.7K | ﹤0.01% |
3,081
-46,764
| -94% | -$906K |
|
1212
Burlington
BURL
$16.8B
| $59.6K | ﹤0.01% |
250
-91,709
| -100% | -$21.9M |
|
1213
Nutanix
NTNX
$21.4B
| $59.3K | ﹤0.01% |
1,050
-21,371
| -95% | -$1.21M |
|
1214
Beam Therapeutics
BEAM
$2.08B
| $58.9K | ﹤0.01% |
2,457
-221,472
| -99% | -$5.31M |
|
1215
Amphastar Pharmaceuticals
AMPH
$1.31B
| $58.9K | ﹤0.01% |
1,460
-16,460
| -92% | -$664K |
|
1216
RPM International
RPM
$16.3B
| $58.2K | ﹤0.01% |
543
-575,976
| -100% | -$61.8M |
|
1217
Rocket Pharmaceuticals
RCKT
$340M
| $58.1K | ﹤0.01% |
2,710
-299,122
| -99% | -$6.41M |
|
1218
Texas Pacific Land
TPL
$21.6B
| $58K | ﹤0.01% |
+79
| New | +$58K |
|
1219
Olin
OLN
$3.02B
| $57.9K | ﹤0.01% |
+1,216
| New | +$57.9K |
|
1220
Sunstone Hotel Investors
SHO
$1.84B
| $57.5K | ﹤0.01% |
5,573
-91,640
| -94% | -$945K |
|
1221
NovoCure
NVCR
$1.38B
| $56.6K | ﹤0.01% |
+3,213
| New | +$56.6K |
|
1222
Vera Therapeutics
VERA
$1.52B
| $56.6K | ﹤0.01% |
1,633
-11,397
| -87% | -$395K |
|
1223
YPF
YPF
$10.6B
| $56.4K | ﹤0.01% |
2,721
-284,256
| -99% | -$5.89M |
|
1224
NCR Voyix
VYX
$1.78B
| $56.3K | ﹤0.01% |
+4,567
| New | +$56.3K |
|
|
MORF
1225
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $56.3K | ﹤0.01% |
1,655
-17,633
| -91% | -$600K |
|